Internal Medicine · Clifton, NJ
NPI
1336444777
Since 2011
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1137 Main Ave
Clifton, NJ, 07011
Phone (973) 405-3900
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
1,056 services
Medicare patients, 2024
187
Average age 74
Drug cost, 2024
$2.5M
15,297 prescriptions
Company payments, 2025
$3,571
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angel R de la Cruz was code 99213 (office e&m - established), 411 times for 159 patients. In total Angel R de la Cruz billed 1,056 services in 37 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 411 | 159 | $66.50 | $27K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 114 | 68 | $49.17 | $5,606 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 77 | 77 | $138.03 | $11K |
| 99214 Office E&M - Established | Office | 73 | 54 | $93.87 | $6,853 |
| 96372 Injection Administration | Office | 48 | 26 | $11.08 | $532 |
| 93922 Duplex Scan - Extremity Arteries | Office | 42 | 38 | $46.03 | $1,933 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 28 | 11 | $0.92 | $25.74 |
| 99442 Telephone Services | Office | 24 | 16 | $74.24 | $1,782 |
| 90661 Vaccine Product | Office | 22 | 22 | $36.11 | $794 |
| G0008 Administration of influenza virus vaccine | Office | 21 | 20 | $35.50 | $746 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 17 | 16 | $12.95 | $220 |
| 94729 Pulmonary Function Testing | Office | 14 | 13 | $46.94 | $657 |
| 94060 Pulmonary Function Testing | Office | 14 | 13 | $33.83 | $474 |
| 94726 Pulmonary Function Testing | Office | 14 | 13 | $46.18 | $646 |
By year: 2022 $82K for 1,375 services; 2023 $63K for 1,134 services; 2024 $63K for 1,056 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82950 Clinical Chemistry | 17 | 13 | $4.69 | $79.8 |
Medicare prescription drug claims, 2024
In 2024, the drug Angel R de la Cruz prescribed most often to Medicare patients was Amlodipine Besylate, with 780 prescriptions and refills. In total Angel R de la Cruz wrote 15,297 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 780 | 2,054 | 274 | $5,394 |
| Atorvastatin Calcium Generic | 761 | 2,102 | 310 | $9,856 |
| Metformin Hcl Generic | 609 | 1,679 | 204 | $4,427 |
| Metoprolol Succinate Generic | 544 | 1,437 | 179 | $8,623 |
| Rosuvastatin Calcium Generic | 422 | 1,138 | 164 | $9,212 |
| Omeprazole Generic | 419 | 846 | 175 | $5,062 |
| Levocetirizine Dihydrochloride Generic | 386 | 572 | 190 | $2,547 |
| Levothyroxine Sodium Generic | 374 | 982 | 129 | $3,440 |
| Losartan Potassium Generic | 362 | 920 | 128 | $3,782 |
| Lisinopril Generic | 347 | 924 | 117 | $2,162 |
| Pantoprazole Sodium Generic | 329 | 699 | 140 | $3,829 |
| Gabapentin Generic | 315 | 628 | 123 | $2,607 |
| Glipizide Er Glipizide | 276 | 756 | 91 | $6,644 |
| Tamsulosin Hcl Generic | 274 | 655 | 93 | $2,928 |
| Meclizine Hcl Generic | 206 | 276 | 106 | $1,390 |
Brand drugs: 2,176 claims; generic drugs: 12,764 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angel R de la Cruz $3,571 ($3,571 in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $941.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 21 | $941 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $913 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $512 |
| Abbvie Inc. ABBV | 18 | $363 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $232 |
| Madrigal Pharmaceuticals MDGL | 1 | $148 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $127 |
| Lilly USA, LLC LLY | 4 | $71.22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $68.44 |
| GlaxoSmithKline, LLC. GSK | 2 | $44.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.